Back to Trades
Total Value
$862.2K
Net $542.4K sold
Filing Date
Jul 24, 2026
1 transaction
Sales
$542.4K
1 transaction
Trade Summary
On Jul 22, 2026, Lee Chan Henry, SVP, General Counsel, sold $862.2K of BeOne Medicines Ltd. (ONC) across 1 transaction. The filing covers company securities and reflects net selling of $542.4K. Reported prices ranged from $159.03 to $325.00. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- BeOne Medicines Ltd.
- Ticker Symbol
- ONC
- CIK
- 0001651308
Insider Information
- Name
- Lee Chan Henry
- Role
- SVP, General Counsel
Filing Details
- Filing Date
- Jul 24, 2026
- Transaction Date
- Jul 22, 2026
- Accession Number
- 0001980648-26-000019
- Form Type
- 4
- Net Trading Amount
- -$542.4K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 22, 2026 | ONC common stock | 514 | $194.47 | Exercise | $100.0K |
| Jul 22, 2026 | ONC common stock | 665 | $213.32 | Exercise | $141.9K |
| Jul 22, 2026 | ONC common stock | 490 | $159.03 | Exercise | $77.9K |
| Jul 22, 2026 | ONC common stock | 1,669 | $325.00 | Sale | $542.4K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 22, 2026 | ONC derivative | 6,682 | — | Exercise | — |
| Jul 22, 2026 | ONC derivative | 8,645 | — | Exercise | — |
| Jul 22, 2026 | ONC derivative | 6,370 | — | Exercise | — |
Want live alerts when Lee Chan Henry trades again?
Download Insider Trades to track ONC, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Each American Depositary Share represents 13 Ordinary Shares.
- (F2)The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.
- (F3)The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.
- (F4)These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- (F5)These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- (F6)These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.